Biotechnology Value Fund L.P. Reduces Stake in MoonLake Immunotherapeutics
Overview of Recent Transaction On October 4, 2024, Biotechnology Value Fund L.P. executed a significant transaction involving the shares of MoonLake Immunotherapeutics (NASDAQ:MLTX). The firm reduced...